Count | |
| 22 | |
| 23 | |
| 6 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 18 | |
| 2 | |
| 1 | |
| 3 | |
| 2 | |
| 1 | |
| 4 | |
| 2 | |
| 4 | |
| 11 | |
| 15 | |
| 16 | |
| 10 | |
| 9 | |
| 2 | |
| 6 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 17 | |
| 1 | |
| 12 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Vasopressins/*antagonists & inhibitors/pharmacology/physiology | 1 |
Vasopressins/antagonists & inhibitors/biosynthesis/*metabolism | 1 |
| 2 | |
Vasopressins/*antagonists & inhibitors/*chemical synthesis/chemistry | 1 |
Vasopressins/administration & dosage/adverse effects/*therapeutic use | 1 |
Neoplasms, Germ Cell and Embryonal/blood/*blood supply/*physiopathology | 1 |
Prostatic Neoplasms/blood/blood supply/*drug therapy/pathology | 1 |
| 1 | |
Polycystic Ovary Syndrome/*blood/blood supply/*surgery/ultrasonography | 1 |
Blood Coagulation Disorders/blood/*etiology/genetics/therapy | 1 |
| 1 | |
| 1 | |
Colorectal Neoplasms/*blood/*blood supply/*diagnosis/surgery | 1 |
Blood Group Incompatibility/*blood/immunology/*prevention & control | 1 |
| 1 | |
Blood Coagulation Disorders/blood/*diagnosis/epidemiology/genetics | 1 |
| 1 | |